Ditto NZ. For the moment I'd settle for a buying announcement to...

Ditto NZ. For the moment I'd settle for a buying announcement to take out some of that sell depth. Hoping the culture within PharmAust permits open answers in the Q&A. I think they're trying, but it doesn't come particularly naturally.

With multiphasic type action we're bound to be unaware of much that goes on and it's so interactive and dynamic that I think dosage sweet spots will be narrowed down by trial and error, rather than by thought.

It's fortunate imo that two things have happened:

- the canine trial accidentally tried trial and error with the MPL absorption rate being so variable. A real bonus as without that we wouldn't have stumbled on Dog 4's performance dose - not yet ideal, but it is interesting
- along the same lines, we now have practically minded vets that are using the same pill plus seem to have the authority to play around with the compassionate use dose. With coal face trial and error once again in action, I think we've again the chance of stumbling on further good dosage outcomes.

Stumbling is a bit harsh but you get the picture